Reagents for SARS-CoV-2 Diagnostic Kit Development
Highly sensitive and specific antibodies and antigens for diagnostic kit development
SARS-CoV-2 infections/COVID-19 can be detected by multiple methods, including nucleic acid detection, antibody detection, and antigen detection. Antibody and antigen detection offer a faster method, making them suitable for rapid screening and instant detection. It is important that antigen and antibodies used in detection kits are of high quality in order to produce a highly sensitive and specific kit. We provide a series of well-established anti-SARS-CoV-2 antibodies, including matched antibody pairs with high sensitivity and affinity, optimized for diagnostic kit development. Alongside these antibodies, we also offer antigens designed for SARS-CoV-2 antibody detection. These are both customizable and available in bulk quantities. These reagents are the latest addition to our ever-expanding COVID-19 research portfolio, which also includes inhibitor screening kits, SARS-CoV-2 pseudolentivirus, and a wealth of recombinant proteins.
Features
- Matched antibody pairs
- Spike and Nucleocapsid antigens for diagnostic kit development
- Customizable antigens
- Bulk quantities available
Applications
- ELISAs
- Chemiluminescent immunoassays
- Gold immunochromatography assays
- Plus many other diagnostic kits
Antibodies for Diagnostic Kit Development
Matched Antibody Pairs
Our matched antibody pairs are suitable for a range of diagnostic assays, including ELISA, chemiluminescent immunoassays, and gold immunochromatography assays. They are optimized for antigen detection kit development and have been verified using inactivated virus samples, with the titer being as low as 102CCID50. Using our matched antibodies, you can reach sensitivities as high as 12 pg/mL in ELISAs!
Features
- High sensitivity of 12 pg/mL (ELISA assay)
- Super affinity of 0.01 nM level (BLI assay)
- Bulk quantities available
Nucleocapsid Protein Antibodies
| Name | Datasheet | Packsize | Order |
|---|---|---|---|
| Anti-SARS-CoV-2 Nucleocapsid Antibody, Mouse IgG1 (AS46) (Trehalose free) |  | 1 mg | View |
| Anti-SARS-CoV-2 Nucleocapsid Antibody, Mouse IgG1 (AS46) (Trehalose free) |  | 100 ug | View |
| Anti-SARS-CoV-2 Nucleocapsid Antibody, Mouse IgG1 (AS47) (Trehalose free) |  | 1 mg | View |
| Anti-SARS-CoV-2 Nucleocapsid Antibody, Mouse IgG1 (AS47) (Trehalose free) |  | 100 ug | View |
| Anti-SARS-CoV-2 Nucleocapsid Antibody, Mouse IgG1 (AS60) | - | 1 mg | View |
| Anti-SARS-CoV-2 Nucleocapsid Antibody, Mouse IgG1 (AS60) | - | 100 ug | View |
| Anti-SARS-CoV-2 Nucleocapsid Antibody, Mouse IgG1 (AS61) | - | 1 mg | View |
| Anti-SARS-CoV-2 Nucleocapsid Antibody, Mouse IgG1 (AS61) | - | 100 ug | View |
S1 Protein Antibodies
Assay Data
Neutralizing Antibodies
Our anti-SARS-CoV-2 RBD neutralizing antibody is isolated from COVID-19 patients and recombinantly produced from HEK293 cells. It is suitable for use as a control for neutralizing antibody titer detection and pseudovirus neutralizing experiments.
Features
- High neutralizing ability and specificity
- Isolated from the convalescent patients' serum
- HEK293 expressed and high batch-to-batch consistency
Assay Data
Human-Derived Antibodies
Our human-derived antibodies are isolated from COVID-19 patients and recombinantly produced from HEK293 cells. They can be used as controls for antibody titer detection, Western blots, and many other applications.
Features
- High specificity
- Isolated from the convalescent patients' serum
- HEK293 expressed and high batch-to-batch consistency
| Name | Datasheet | Packsize | Order |
|---|---|---|---|
| Anti-SARS-CoV-2 Nucleocapsid Antibody, Human IgG1 (AS41) | - | 1 mg | View |
| Anti-SARS-CoV-2 Nucleocapsid Antibody, Human IgG1 (AS41) | - | 100 ug | View |
| Anti-SARS-CoV-2 Nucleocapsid Antibody, Human IgG1 (AS42) | - | 1 mg | View |
| Anti-SARS-CoV-2 Nucleocapsid Antibody, Human IgG1 (AS42) | - | 100 ug | View |
| Anti-SARS-CoV-2 Nucleocapsid Antibody, Human IgG1 |  | 1 mg | View |
| Anti-SARS-CoV-2 Nucleocapsid Antibody, Human IgG1 |  | 100 ug | View |
Assay Data
Antigens for Diagnostic Kit Development
These SARS-CoV-2 Spike and Nucleocapsid antigens are specifically designed for COVID-19 diagnostic kit development. We are able are customize these to your specific needs, as well as providing bulk quantities. They are suitable for a range of antibody detection methods, including chemiluminescent immunoassays, ELISAs, and gold immunochromatography assays.
Features
- Customizable antigens
- Available for bulk order
- Optimized for antibody detection
| Product Code | Protein | Host | Tag | Recommended Application | Recommended Method |
|---|---|---|---|---|---|
| AMS.SPN-C52H2 | S protein | HEK293 | His tag | Detect IgG/IgM by capture method |
|
| AMS.S1N-C52H2 | S1 protein | His tag | |||
| AMS.S1N-C82E8 | His tag, Avi tag | ||||
| AMS.S2N-C52H2 | S2 protein | His tag | |||
| AMS.SPD-C52H1 | S protein RBD | His tag | Detect total antibodies by double antigen sandwich method | ||
| AMS.SPD-C52H2 | His tag | Detect IgG/IgM by capture method | |||
| AMS.SPD-C82E9 | His tag, Avi tag | ||||
| AMS.NUN-C5221 | Nucleocapsid protein | His tag | |||
| AMS.NUN-C51H2 | E. coli | His tag | |||
| AMS.ENN-C5128 | Envelope protein | HEK293 | GST tag, His tag |
Assay Data
